Examkin

Soru

Zorluk: OrtaSchizophrenia and Psychotic Disorders

Match each clinical presentation or medication adverse effect with the corresponding dopaminergic pathway involved in its pathophysiology.

  • A 23-year-old man with schizophrenia develops severe restlessness and an inability to sit still (akathisia) after starting haloperidol.Nigrostriatal pathway
  • A 28-year-old woman with schizophrenia presents with amenorrhea and galactorrhea after several months of treatment with risperidone.Tuberoinfundibular pathway
  • A 22-year-old man is brought to the emergency department experiencing command auditory hallucinations and prominent persecutory delusions.Mesolimbic pathway
  • A 35-year-old man with a long-standing history of schizophrenia exhibits pronounced flat affect, severe social withdrawal, and poverty of speech.Mesocortical pathway

Cevap

Akathisia matches to Nigrostriatal pathway. Galactorrhea matches to Tuberoinfundibular pathway. Positive symptoms (hallucinations/delusions) match to Mesolimbic pathway. Negative symptoms (flat affect) match to Mesocortical pathway.
There are four main dopaminergic pathways relevant to schizophrenia and antipsychotic pharmacology. The mesolimbic pathway is associated with positive symptoms due to excess dopamine. The mesocortical pathway is associated with negative symptoms due to a dopamine deficit. The tuberoinfundibular pathway regulates prolactin; dopamine blockade here causes hyperprolactinemia. The nigrostriatal pathway regulates movement; dopamine blockade here causes extrapyramidal symptoms.

Adım Adım Çözüm

1
Identify the primary clinical manifestation in each patient scenario.
Patient 1 has extrapyramidal symptoms (akathisia). Patient 2 has hyperprolactinemia (amenorrhea, galactorrhea). Patient 3 has positive psychotic symptoms (hallucinations, delusions). Patient 4 has negative psychotic symptoms (flat affect, avolition).
Recognizing the specific symptom cluster or medication side effect is necessary to map it to the correct neuroanatomical pathway.
2
Map the positive and negative symptoms of schizophrenia to their respective dopaminergic pathways.
Positive symptoms correlate with mesolimbic hyperactivity. Negative symptoms correlate with mesocortical hypoactivity.
This is the foundational dopamine hypothesis of schizophrenia.
3
Map the adverse effects of antipsychotic medications to their respective dopaminergic pathways.
Extrapyramidal symptoms map to the nigrostriatal pathway. Hyperprolactinemia maps to the tuberoinfundibular pathway.
Antipsychotics block D2 receptors, leading to therapeutic effects in the mesolimbic pathway but off-target adverse effects in the nigrostriatal and tuberoinfundibular pathways.

Anahtar Kavram

Dopaminergic pathways in schizophrenia and antipsychotic adverse effects.
Bu soruyu puanla

Konular

Schizophrenia and Psychotic Disorders

Bu konudan daha fazla soru